FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095032 [Registered on: 18/09/2025] Trial Registered Prospectively
Last Modified On: 17/09/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   A study to evaluate the use of the RIST device for radial artery access in patients undergoing brain and nerve vessel procedures at an Indian hospital. 
Scientific Title of Study   Evaluation of Radial Access for Neurointerventional Procedures Using the RIST Radial Access System in an Indian Neurovascular Center 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Tariq Matin 
Designation  Director & Chief, Neurointerventional Surgery 
Affiliation  Artemis Hospitals 
Address  Department of Neuro Sciences CREST Neuroscience Artemis Hospitals Sector 51 Gurugram Bindapur

Gurgaon
HARYANA
122001
India 
Phone  9891047587  
Fax    
Email  tariqmatin@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Tariq Matin 
Designation  Director & Chief, Neurointerventional Surgery 
Affiliation  Artemis Hospitals 
Address  Department of Neuro Sciences CREST Neuroscience Artemis Hospitals Sector 51 Gurugram Bindapur

Gurgaon
HARYANA
122001
India 
Phone  9891047587  
Fax    
Email  tariqmatin@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Vikas Salgotra 
Designation  Associate Director-Clinical Research 
Affiliation  Department of Clinical Research 
Address  Turacoz Healthcare Solutions Pvt Ltd Unit no. 991 and 992 9th floor Vegas Mall Plot no 6 Sector 14 Dwarka

South West
DELHI
110078
India 
Phone  9833950222  
Fax    
Email  vikas.salgotra@turacoz.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  CREST Neuroscience, Artemis Hospital 
Address  Department of Neuroscience, Artemis Hospitals, Sector 51 Gurugram, Bindapur Haryana 122001 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mukesh Kumar  Artemis Hospitals  Room no 01, Department of Neurointerventional Surgery
Gurgaon
HARYANA 
8384909673

mukesh.capt@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Artemis Health Sciences-Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I679||Cerebrovascular disease, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Patients aged 12 years or older.
2. The presence of an adequate radial artery diameter, defined as greater than equal to 1.7 mm, as confirmed
through pre-procedural ultrasound evaluation.
3. Patients who have undergone procedure by RIST series of catheter.
4. Favorable aortic arch anatomy, assessed via computed tomography angiography (CTA) or
digital subtraction angiography (DSA), deemed suitable for radial access.
5. Willing to provide written informed consent. 
 
ExclusionCriteria 
Details  1. Presence of severe peripheral vascular disease or anatomical abnormalities of the radial
artery e.g., radial artery loop that may hinder safe catheter navigation.
2. History of previous ipsilateral radial artery occlusion.
3. Contraindications to radial access, such as significant arterial calcification or vasospasm
identified on ultrasound imaging 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The primary outcome of the study is the effectiveness of catheterization using the RIST radial access
system. Catheterization will be considered effective if the operator is able to navigate the Rist catheter
to the desired target vessel via TRA without crossover to an alternate access site 
Baseline Procedure 
 
Secondary Outcome  
Outcome  TimePoints 
1. Procedural success rate: Defined as the ability to complete the intracranial portion of the procedure
without switching to a different access site or guide catheter.
2. Assessed using access site and procedure-related complications. Access site
complications: These will include radial artery spasm, hematoma, radial artery occlusion, dissection,
or pseudoaneurysm. Each event will be documented, categorized by severity, and attributed to the
device or technique where applicable. All events will be graded using the Common Terminology
Criteria for Adverse Events (CTCAE). 
7 days post procedure  
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a prospective single center observational study being conducted at Artemis Hospital, Gurugram, India. The study will enroll 100 patients (older than 12 years) undergoing elective or emergency neurointerventional procedures using the RIST Radial Access System. The primary aim is to assess catheterization success via transradial access without conversion to another route. Secondary objectives include evaluating procedural success rates and safety outcomes such as radial artery spasm, occlusion, hematoma, and procedure-related complications. Data will be collected until hospital discharge using an electronic CRF. The study is investigator-initiated, self-funded, and will follow ICH GCP and local ethical guidelines. Results will provide important evidence on the feasibility and safety of RIST device use in Indian neurovascular practice 
Close